These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 21198747)

  • 1. New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins.
    Sioud M
    Scand J Immunol; 2011 Feb; 73(2):79-84. PubMed ID: 21198747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins.
    Sioud M; Mobergslien A; Boudabous A; Fløisand Y
    Int J Oncol; 2011 Feb; 38(2):385-90. PubMed ID: 21165555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
    Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
    Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions.
    Najar M; Raicevic G; Id Boufker H; Stamatopoulos B; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
    Exp Hematol; 2010 Oct; 38(10):922-32. PubMed ID: 20570633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation.
    Sioud M; Mobergslien A; Boudabous A; Fløisand Y
    Scand J Immunol; 2010 Apr; 71(4):267-74. PubMed ID: 20384870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells.
    English K; Barry FP; Field-Corbett CP; Mahon BP
    Immunol Lett; 2007 Jun; 110(2):91-100. PubMed ID: 17507101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
    DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D
    Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells.
    Jones BJ; Brooke G; Atkinson K; McTaggart SJ
    Placenta; 2007; 28(11-12):1174-81. PubMed ID: 17714779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype.
    Maccario R; Podestà M; Moretta A; Cometa A; Comoli P; Montagna D; Daudt L; Ibatici A; Piaggio G; Pozzi S; Frassoni F; Locatelli F
    Haematologica; 2005 Apr; 90(4):516-25. PubMed ID: 15820948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism.
    Djouad F; Charbonnier LM; Bouffi C; Louis-Plence P; Bony C; Apparailly F; Cantos C; Jorgensen C; Noël D
    Stem Cells; 2007 Aug; 25(8):2025-32. PubMed ID: 17510220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes.
    Le Blanc K; Rasmusson I; Götherström C; Seidel C; Sundberg B; Sundin M; Rosendahl K; Tammik C; Ringdén O
    Scand J Immunol; 2004 Sep; 60(3):307-15. PubMed ID: 15320889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.
    Opitz CA; Litzenburger UM; Lutz C; Lanz TV; Tritschler I; Köppel A; Tolosa E; Hoberg M; Anderl J; Aicher WK; Weller M; Wick W; Platten M
    Stem Cells; 2009 Apr; 27(4):909-19. PubMed ID: 19353519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
    Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
    Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation.
    Nasef A; Zhang YZ; Mazurier C; Bouchet S; Bensidhoum M; Francois S; Gorin NC; Lopez M; Thierry D; Fouillard L; Chapel A
    Int J Lab Hematol; 2009 Feb; 31(1):9-19. PubMed ID: 19143868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.
    Ramasamy R; Tong CK; Seow HF; Vidyadaran S; Dazzi F
    Cell Immunol; 2008 Feb; 251(2):131-6. PubMed ID: 18502411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells.
    Yañez R; Oviedo A; Aldea M; Bueren JA; Lamana ML
    Exp Cell Res; 2010 Nov; 316(19):3109-23. PubMed ID: 20804749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cells: Tissue repair and immune modulation.
    Le Blanc K
    Cytotherapy; 2006; 8(6):559-61. PubMed ID: 17148032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia.
    Bacigalupo A; Valle M; Podestà M; Pitto A; Zocchi E; De Flora A; Pozzi S; Luchetti S; Frassoni F; Van Lint MT; Piaggio G
    Exp Hematol; 2005 Jul; 33(7):819-27. PubMed ID: 15963858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
    Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
    Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression by mesenchymal stromal cells: from culture to clinic.
    Jones BJ; McTaggart SJ
    Exp Hematol; 2008 Jun; 36(6):733-41. PubMed ID: 18474304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.